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Abstract  21 
The present study aimed to examine the putative preventive effect of the ethanolic extract 22 
Date Palm Pollen (DPP, Phoenix dactylifera L., family Arecaceae) on isoproterenol-induced 23 
myocardial infarction (MI) in rats. Twenty four rats were randomly divided into four groups 24 
including control. They were treated with DPP extract (400 mg/kg) and clopidogrel (0.2 25 
mg/kg) for 7 days followed by myocardial injury induction using subcutaneous isoproterenol 26 
(100 mg/kg) with an interval of 24h for two days (6th and 7th day). Administration of 27 
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isoproterenol exhibited indicative changes in the ECG pattern evidenced by significant 28 
elevation of ST-segment and cardiac injury markers viz.; troponin-T, creatine phosphokinase 29 
(CPK), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) by 315%, 71%, 30 
64% and 170%, respectively as compared to control. Additionally, the angiotensin-converting 31 
enzyme (ACE) activity in plasma was increased by 33% associated to histological myocardial 32 
necrosis. However, pre-co-treatment with DPP extract improved the cardiac biomarkers 33 
injury, normalized cardiac function indices and prevented the ventricular remodeling process 34 
through inhibition of ACE activity by 34% and the inhibition of the generation of radical 35 
oxygen species. Extensive characterization of this DPP extract using LC-HRMS revealed 36 
numerous flavonoids and phenols compounds which could be endowed with cardiopreventive 37 
actions. Overall, these results proved that DPP extract has preventive effects on cardiac 38 
remodeling process. 39 
Keywords: «DPP ethanolic extract; cardiopreventive; myocardial infarction; ACE; ECG; 40 
Electrospray Ionization Mass Spectrometry». 41 
Abbreviations: DPP, Date Palm Pollen; MI, myocardial infarction; HRESIMS, high 42 
resolution electrospray ionization mass spectrometry; ECG, electrocardiographic; LV, left 43 
ventricular; CPK, creatine phosphokinase; ALT, alanine aminotransferase; LDH, lactate 44 
dehydrogenase; ACE, angiotensin-converting enzyme; TC, total cholesterol; TG, 45 
triglycerides; ECL, electrochemiluminescence; ROS, reactive oxygen species.  46 
 47 
1. Introduction 48 
Cardiovascular diseases remain the most important cause of mortality in both developed 49 
and developing countries, accounting approximately 20% of all annual deaths worldwide 50 
(Ittagi et al., 2014). The cardiovascular system is susceptible to many chronic diseases such as 51 
hypertension and myocardial infarction. The myocardial infarction (MI) reflects the death of 52 
cardiac myocytes due to prolonged ischemia. It is considered an acute coronary syndrome that 53 
may happen during the natural path of coronary atherosclerosis. This pathology could be 54 
mediated to several factors affecting the arterial wall (Boersma et al., 2003). Hence, it is a 55 
result of imbalance between coronary blood supply and cardiac demand (Mnafgui et al., 56 
2016). It increases myocardial necrosis which causes cardiac dysfunction including blood 57 
pressure, heart rate and electrocardiographic (ECG) changes and left ventricular (LV) 58 
dysfunction associated with an alteration in activities of cardiac-specific enzymes. Cardiac 59 
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troponins are frequently accompanied with inflammation-related proteins and myocardial 60 
infarction in case of severe heart damage (Mnafgui et al., 2016).  61 
Isoproterenol [1-(3,4-dihydroxyphenyl)-2-isopropylaminoethanol HCl] is a synthetic 62 
catecholamine with β-adrenergic agonist effect which shown to cause severe stress in the 63 
myocardium resulting in infarction-like necrosis of the heart muscles (Upaganlawar et al., 64 
2011). However, the administration of isoproterenol in supra-maximal doses could stimulate 65 
subendocardial ischemia, necrosis, hypoxia followed by fibroblastic hyperplasia with 66 
decreased myocardial compliance and inhibition of diastolic and systolic function 67 
(Mehdizadeh et al., 2013). In veterinary and human medicine, numerous synthetic drugs were 68 
designed for the management of heart attack but exhibit many side effects. Hence, several 69 
attempts have been taken for the identification of new therapeutic approaches to prevent 70 
myocardial infarction. A great attention has been given to the polyphenols as effective 71 
bioactive compounds that protect cells from myocardial damage. Naturally-occurring 72 
polyphenolic compounds with antioxidant properties are widely in vegetables, fruits, tea, etc 73 
(Hertog et al., 1993).  74 
Historically, date palm trees (Phoenix dactylifera L.) belonging to family Arecaceae were 75 
extensively used in folk medicine as potential source for treatment of many human diseases. 76 
Date Palm Pollen (DPP) has been reported as rich source of diverse secondary metabolites 77 
that elucidate its potential uses in several disorders. Antioxidants play a significant action as 78 
preventive agents via neutralization or inhibition of reactive oxygen species (ROS) that 79 
suppress the development and progression of many diseases. Recent investigations reported 80 
that date palm possesses a potent ability to neutralize free radical (Rahmani et al., 2014; Al-81 
Farsi et al., 2005). Accordingly, the DPP proved effective in many biological proprieties such 82 
as aphrodisiac, anti-inflammatory, anti-coccidial, anti-apoptotic (Elberry et al., 2011; 83 
Metwaly et al., 2014), anti-toxicant (Eraslan et al., 2008), and hepato-protective (Uzbekova et 84 
al., 2003) activities.  85 
Despite this large flow of data on the promising properties and attributes of DPP, no 86 
studies have been performed to explore the preventive effect of DPP against experimentally-87 
induced myocardial infarction in rats. This encouraged us in the current study to explore this 88 
effect with scientific evidence.   89 
2. Materials and methods 90 
2.1. Chemicals 91 
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Isoproterenol hydrochloride powder obtained from Sigma-Aldrich (Sigma-Aldrich, St. 92 
Louis, USA). ACE kit was purchased from Trinity (Trinity, UK). All other chemicals used in 93 
this study were analytical grade. 94 
2.2. DPP collection  95 
DPP was collected from Phoenix dactylifera L., family Arecaceae in Tozeur (South-west, 96 
Tunisia) in April 2015. After collection, the pollen was air-dried and ground to fine powder 97 
using a grinder. The powdered material was stored at 4 °C until further use. Its botanical 98 
identification and authentication were confirmed at the Department of Botany of the 99 
University of Sfax (Tunisia). 100 
2.3. Extraction of plant material 101 
Sample of powdered plant material (200 g) was extracted twice with 800 mL of ethanol 102 
for 24 h. The macerate was then filtered through filter paper (Whatman, Sfax, Tunisia) in a 103 
Buchner funnel. The filtered solution was evaporated in a rotary evaporator under vacuum at 104 
45 °C till complete dryness. The dry extract and stock solution were kept at 4 °C until further 105 
analysis. 106 
2.4. Animals 107 
A total of 24 adult male Wistar rats, weighing 170-190 ± 10 g, were obtained from the 108 
local Central Pharmacy (Tunisia) and used in the present study. The animals were housed in 109 
clean cages in an air conditioned room and kept under standard conditions of temperature (25 110 
± 2 °C), humidity (60 ± 5%) and light (12 h dark/12 h light cycle). They were kept on 111 
standard diets and free access to tap water. The experimental protocols were conducted in 112 
accordance with the guide for the care and use of laboratory animals issued by the University 113 
of Sfax (Tunisia), and approved by the Committee of Animal Ethics. 114 
2.5. Induction of experimental myocardial infarction 115 
Isoproterenol was dissolved in normal saline solution and injected to rats (100 mg/kg) at 116 
an interval of 24 h for 2 consecutive days to induce experimental myocardial infarction 117 
(Mnafgui et al., 2016). Animals were sacrificed 48 h after the first dose of isoproterenol. 118 
2.6. Experimental protocols  119 
After acclimatization, the animals were randomly divided into four groups of six rats 120 
each as following: 121 
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Group 1: (Control) rats, received standard laboratory diet and allowed to drink saline water ad 122 
libitum, served as a control; 123 
Group 2: isoproterenol (Isop) rats, received saline water and standard diet for 7 days. At the 124 
6th day these rats were subcutaneously injected with Isoproterenol (100 mg/kg), once at an 125 
interval of 24 h for two consecutive days to induce myocardial infarction; 126 
Group 3: (Isop+Clop) rats received clopidogrel (trade name Plavix, 0.2 mg/kg by gastric 127 
gavages) for 7 days and were injected subcutaneously with isoproterenol (100 mg/kg) on days 128 
6 and 7. 129 
Group 4: (Isop+DPP) rats received the ethanolic extract of DPP (400 mg/kg) for 7 days and 130 
were injected subcutaneously with isoproterenol (100 mg/kg) on the 6th and 7th days. All rats 131 
were fasted overnight but had free access to water at the last administration of the drug. After 132 
the 7 days induction, the animals were weighted and sacrificed by decapitation in order to 133 
minimize the handling stress. The trunk blood and heart were collected. Plasma was obtained 134 
by cold centrifugation of the blood (1500 × g, 15 min), frozen and stored at -20 °C till further 135 
use for the biochemical assays. Immediately after sacrifice, the heart was excised out, rinsed 136 
with saline and fixed in a Bouin solution for 24 h and embedded in paraffin. The sections of 5 137 
µm thickness were stained with Hematoxylin–Eosin (H&E). The slides were examined under 138 
light microscope and photomicrographs were taken by an Olympus U-TU1X-2 camera 139 
connected to an Olympus CX41 microscope (Tokyo, Japan) (Mnafgui et al., 2016). 140 
2.7. Electrocardiography  141 
The ECG patterns were recorded using veterinary electrocardiograph (ECG VET 110, 142 
Biocare, China). ECG recording were made in anesthetized with ketamine (100 mg/Kg) 143 
intraperitoneally, at the end of the experimental period (24 h after the second dose of 144 
isoproterenol). Needle electrodes were inserted under the skin of the animals under light ether 145 
anesthesia in lead II position. The ECG record period was between 15-30 seconds. 146 
2.8. Biochemical analysis  147 
Following blood collection, animals were sacrificed and mid abdominal incision was 148 
processed in order to dissect out the heart. It was weighed and further subjected for 149 
histopathological analysis. The collected plasma was used for the determination of ACE using 150 
the available commercial kit from Trinity (Trinity, UK). Cardiac dysfunction markers CPK, 151 
LDH and ALT were measured in frozen aliquots of plasma by standardized enzymatic 152 
procedures using commercial kits from Abbott (Abbott, USA). The levels of plasma cardiac 153 
troponin-T were measured using Roche's electrochemiluminescence (ECL) technology 154 
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(Roche Diagnostics, Switzerland). The lipid profile including total cholesterol (CT) and 155 
triglycerides (TG) were measured in frozen aliquots of serum by standardized enzymatic 156 
procedures using commercial kits from Abbott (Abbott, France) on an automatic biochemistry 157 
analyzer (Architect ci 4100, USA) at the clinical pathological laboratory of Sfax Hospital. 158 
2.9. LC/HRMS analysis 159 
High resolution mass spectral data were obtained on a Thermo Instruments ESI-MS 160 
system (LTQ XL/LTQ Orbitrap Discovery, UK) connected to a Thermo Instruments HPLC 161 
system (Accela PDA detector, Accela PDA autosampler and Accela Pump). A reversed-phase 162 
column (Pursuit XRs ULTRA 2.8, C18, 100 x 2 mm, Agilent Technologies, UK) was used to 163 
carry out the analyses. The volume of the injected sample was set at 20 µl and 30 °C was 164 
chosen for column temperature. Mobile phases A and B, consisted of 0.1% formic acid in 165 
water and MeOH, respectively. For separation at a flow rate of 1 ml/min, a gradient program 166 
was used. 100% solvent A was the initial mobile phase, followed by a gradient to 100% 167 
solvent B over 20 minutes, the mobile phase was then hold on 100% solvent B for 5 min and 168 
to 100% solvent A for 25 min. Drying gas flow rate was 1 ml/min at 320 °C. MS was 169 
operated in the positive ion mode in a mass range of m/z 100-2000.  170 
2.10. Statistical analysis 171 
Data are presented as mean ± standard deviation (SD).Values were derived from six 172 
animals per group, and differences were examined by a one-way analysis of variance 173 
(ANOVA) followed by the Fisher test (Stat View). *P < 0.05 was considered statistically 174 
significant. 175 
3. Results 176 
3.1. Effect of DPP ethanolic extract on body and heart weight of experimental rats  177 
The effects of isoproterenol and DPP extract treatment on heart weight, body weight and 178 
heart weight to body weight ratio are shown in Table 1. There is no significant difference in 179 
the body weight between the groups observed. Isoproterenol treated rats showed a significant 180 
increase (P < 0.05) in heart weight and heart weight to body weight ratio by 41% as compared 181 
to control rats. However, rats pretreated with DPP extract followed by isoproterenol exhibited 182 
notable decrease (P < 0.05) in the heart weight by 22% compared to untreated myocardial 183 
infarcted rats. Moreover, no significant difference was observed in heart weight and heart 184 
weight to body ratio between animals treated with DPP extract and those treated with 185 
clopidogrel. 186 
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3.2. Effect of DPP-T on ECG pattern 187 
Fig. 1 and Fig. 2 represented the electrocardiogram pattern of normal and experimental 188 
rats, respectively. Control animals exhibited normal ECG pattern. Rats treated only with 189 
isoproterenol showed significant increase of ST–segment (P < 0.05) compared to control 190 
group, indicating infarcted myocardium. Also, isoproterenol treated rats illustrated the 191 
incidence of wave of Pardee and planing R-wave equivalent of the Q wave of necrosis. 192 
However, the treatment of infarcted rats with clopidogrel and DPP extract exhibited a 193 
remarkable decrease of ST-segment compared to untreated ones. Additionally, rats treated 194 
with DPP extract or clopidogrel showed a whole neutralization of the ST-segment elevation 195 
with normal QRS compared to Isoproterenol treated ones. 196 
3.3. Plasma markers of cardiac damage  197 
Table 2 indicated the effects of DPP extract on marker enzymes of cardiac function 198 
including CPK, ALT, LDH and tropornin-T in serum of control and experimental rats. The 199 
plasma enzyme activities of CPK, ALT, LDH and tropornin-T were significantly increased (P 200 
< 0.05) in the isoproterenol-induced infarcted rats by 71, 64, 170 and 315%, respectively 201 
compared to control rats. However, pre-co-treatment of infarcted rats with DPP extract 202 
significantly (P < 0.05) normalized the cardiac function indices. 203 
3.4. Plasma lipid profile 204 
As shown in Table 3, isoproterenol-induced myocardial infarcted rats displayed 205 
significant increase in the plasma concentration of total cholesterol and triglycerides (P < 206 
0.05) compared to control group. DPP extract pre-co-treatment significantly decreased the 207 
plasma levels of cholesterol and triglycerides compared to isoproterenol group. 208 
3.5. Histopathological examination  209 
As shown in Fig. 3, control rats exhibited normal myocardium structure without any 210 
infarction edema. However, the isoproterenol-induced infarcted rats showed clear increase in 211 
myofibril thickness, necrosis, and loss of transverse striations compared to control group. 212 
However, pre-co-treatment of infarcted rats with DPP showed normal myocardial 213 
architectures with evident transverse striations. 214 
3.6. Effect of ethanolic extract of DPP on plasma ACE Activity 215 
As shown in Fig.4, the ACE activity in plasma of untreated infarcted rats showed a 216 
significant increase by 33% as compared to control group of rats (P < 0.05). Interestingly, the 217 
treatment of infarcted rats with DPP extract underwent a notable decrease of ACE activity by 218 
34% as compared to the untreated infarcted group. 219 
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3.7. LC/MS analysis of bioactive compounds in DPP extract 220 
LC/HRESIMS analysis of the DPP extract showed a rich profile of 29 secondary 221 
metabolites belonging to two main chemical classes (Fig. 5).  Phenolic compounds, including 222 
flavonoids, flavonoid derivatives, flavonoid glycosides, tannins, coumarins, and other 223 
phenolic derivatives, stand for approximately 60% of the total DPP metabolite profile.  224 
Additionally, terpenoid compounds, including carotenoid derivatives, steroids, fatty acids, and 225 
other terpene derivatives represent about 40% of the total DPP metabolite profile. About 60% 226 
of the detected metabolites proved to possess either a cardioprotective effect, protects against 227 
myocardial infarction or ACE enzyme inhibitors (Table 4). Even there was no reported 228 
activity for the remaining 40% of the detected metabolites, they could have potential 229 
antioxidant or free radical scavenging effect due to their phenolic scaffold. 230 
4. Discussion 231 
DPP has been reported as a rich source of diverse secondary metabolite possessing free 232 
radical scavenging potential that may overcome heart disease (Daoud et al., 2015). The 233 
present study was designed to investigate, for the first time, the preventive effect of DPP 234 
ethanolic extraction against isoproterenol-induced myocardial function in rats.  235 
A subcutaneous injection of supra-maximal dose of isoproterenol has been reported to 236 
cause severe myocardial stress and induce infarction such as necrosis which is followed by 237 
increased release of cardiac enzymes, accumulation of lipid peroxidases, and impaired cardiac 238 
function (Jing et al., 2014). Rats treated with isoproterenol showed an obvious elevation of 239 
ST-segment. Accordingly, Rajadurai et al. (2007) recorded that modification of ST-segment is 240 
indicative of myocardial ischemia and infarction. The alteration of ECG pattern is related to 241 
the consecutive loss of integrity of cell membrane in injured myocardium (Mnafgui et al., 242 
2016). However, administration of DPP ethanolic extract in a dose of 400 mg/kg reduced the 243 
abnormalities observed in the ECG of isoproterenol-induced rats. Therefore, DPP remarkably 244 
restored the alteration of ST-segment induced by isoproterenol, suggesting the preventive 245 
effects of DPP extract on cell membrane. 246 
The evaluation of myocardial cell injury was performed by the determination of specific 247 
and sensitive biomarkers in plasma like troponin-T, CPK, ALT and LDH (O’Brien et al., 248 
2006; Evran et al., 2014; Mnafgui et al., 2016). In the current study, the significant increase in 249 
plasma biomarkers activities have been recorded in isoproterenol group as compared to 250 
control. The high level of troponin-T and plasma cardiac markers predicts the risk of both 251 
cardiac death and subsequent infarction (Acikel et al., 2005; Rajadurai et al., 2007). Pre-co-252 
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treatment with DPP extract showed an improvement in the levels of plasma cardiac enzymes 253 
in isoproterenol-induced rats. These results suggest that DPP could reduce the degree of 254 
damage in the myocardium by maintaining membrane integrity and therefore, restricting the 255 
leakage of these enzymes. 256 
On the other hand, lipids play a crucial role in cardiovascular diseases not only in 257 
hyperlipidemia and the development of atherosclerosis, but also by modifying the structure, 258 
composition, and stability of the cellular membranes (Saxena and Panjwani, 2014; Shaik et 259 
al., 2012). An increase in total lipid levels (TG and CT) was detected in isoproterenol-injected 260 
rats that could enhance the induction of the atherosclerotic plaque, associated with myocardial 261 
infarction. The obtained results proved that the pre-co-treatment with DPP extract ameliorated 262 
the status of isoproterenol-induced cardio toxicity in rats. This underlines that DPP extract is 263 
responsible for protection of structural and architectural integrity of cardiomyocytes. The 264 
current findings showed that DPP provided a preventive effect to the myocardium by 265 
attenuation of ventricular dysfunction through maintaining the ECG pattern and cardiac 266 
markers enzymes near to normal condition in isoproterenol-treated rats. 267 
Scientific evidences have suggested that the cardiac renin-angiotensin system (RAS) was 268 
activated during the remodeling process after acute myocardial infarction (Mnafgui et al., 269 
2016; Harada et al., 1999; Borghi et al., 2006). The myocardial infarction induced by 270 
isoproterenol is often underwent a significant rise in ACE activity associated with elevation in 271 
heart weight ratio indicative of ventricular remodeling process. This mechanism improves the 272 
dilation of the non-infarcted left ventricular, the infarct expansion as well as the compensatory 273 
reactive hypertrophy (Mnafgui et al., 2016; Borghi et al., 2006). The increase in the ACE 274 
activity certainly report the inhibition of cardiac remodeling process by reducing the 275 
expression of cytokine transforming growth factor (TGF-β1) which is a mediator of the 276 
remodeling process and fibrosis tissues (Mnafgui et al., 2016). The oral administration of DPP 277 
extract to isoproterenol-induced infarcted rats contributed to a significant inhibition of plasma 278 
ACE activity with remarked decrease in heart weight ratio. Interestingly, our results highlight 279 
the cardiopreventive effect of DPP preventing the increased risk of infarct expansion and LV 280 
remodeling following myocardial infarction. In fact, numerous clinical and experimental 281 
studies revealed that the activity of cardiac rennin-angiotensin system is started after 282 
myocardial infarction and failure (Teyssedou, 2007; Mnafgui et al., 2016). The current results 283 
evidenced that the DPP extract prevented the excessive heart fibrosis. It has been proved, for 284 
the first time that stimulates the systolic and diastolic improvement through increasing the 285 
pumping capacity and restoring the myocardial stiffness (Kannan et al., 2011). 286 
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LC/HRESIMS analysis of the DPP extract indicated a rich profile of many secondary 287 
metabolites belonging to two main chemical classes.  Approximately 60% of the total DPP 288 
metabolite profile was accounted to phenolic compounds with different subclasses while 289 
terpenoid derivatives represent around 40% of the total DPP metabolite profile. Literature 290 
review of their biological activity revealed that 60% of the identified compounds have 291 
potential cardiopreventive, anti-myocardial infarction effects and ACE inhibition activities. 292 
For example, the terpenoids stigmasterol (Li et al., 2015), β-sitosterol (Lei et al., 2015) and 293 
estradiol (Lagranha et al., 2010), the carotenoids lutein (Zou et al., 2011 and 2014) and δ-294 
tocotrienol (Wong et al., 2015), and flavonoids isorhamnitin (Ibarra et al., 2002) exhibited 295 
cardiopreventive effect. Additionally, some metabolites reported to be protective agents 296 
against harmful effects of myocardial infarction including the steroid β-sitosterol acetate (Lei 297 
et al., 2015) and the phenolic derivatives catechin (Bhardwaj et al., 2014), apigenin (Du et al., 298 
2015), and methyl-p-hydroxycinnamate (Jyoti Roy and Stanley Maynzen Prince, 2013). 299 
Moreover, our survey on the identified bioactive molecules in DPP extract revealed their in 300 
vivo ACE inhibitory activity such as estradiol (Dean et al., 2005), ellagic acid (Al Shukor et 301 
al., 2013), luteolin, quercitin, apigenin and rutin (Guerrero et al., 2012), quercitrin (Hackl et 302 
al., 2002), luteolin-7-O-glucoside (Simaratanamongkol et al., 2014) and ferulic acid (Geng et 303 
al., 2010). Finally, there was no reported activity for the remaining 40% of the detected 304 
metabolites, they could have potential antioxidant or free radical scavenging effect due to 305 
their phenolic scaffold. These compounds warrant urgent investigation of their 306 
cardiopreventive anti-myocardial infarction effects and ACE inhibition activities in the light 307 
of our results.  308 
5. Conclusion  309 
Herein, we represent the first experimental evidence that DPP exerted cardiopreventive 310 
effect from the acute myocardium infarction and cardiac remodeling process induced by 311 
isoproterenol through the inhibition of ACE activity. This was supported by the presence of 312 
different DPP metabolites belonging to different chemical scaffolds with documented 313 
cardiopreventive, anti-myocardial infarction effects and ACE inhibition activities. DPP could 314 
therefore be regarded as a promising cardiopreventive agent and rich source of bioactive 315 
pharmacological products. 316 
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Figure captions 511 
Fig. 1. Effect of DPP ethanolic extract on ST-segment elevation (mV) in the ECG (recorded 512 
from limb lead II) in normal control, isoproterenol alone injected and treated rats. Values are 513 
given as mean ± SD for group of six rats. Statistically, values are represented as follows: * P 514 
< 0.05 significant differences compared to controls. # P < 0.05 significant differences 515 
compared to isoproterenol group. @ P < 0.05 significant differences compared to 516 
isoproterenol-treated group with clopidogrel. 517 
Fig. 2. Effect of DPP ethanolic extract on electrocardiographic (ECG) pattern in normal and 518 
experimental rats. 519 
Fig. 3. Histopathological changes of myocardial tissue (H&E9500).Control group showing 520 
normal myocardial histology, clear transverse striations and no inflammatory cell infiltration. 521 
Isoproterenol (Isop) group showing myocardial cells necrosis, separation of cardiac 522 
myofibrillar and large inflammatory cells infiltration. Isop +Clop (0.2 mg/kg)-treated group 523 
showing few inflammatory cell infiltration and improvement of myocardium necrosis. Isop + 524 
DPP (400 mg/kg) showing normal myocardial architectures with evident transverse striations. 525 
Fig. 4. ACE activity in serum of normal and experimental rats. Values are given as mean ±  526 
SD for group of six rats. Statistically, values are represented as follows: * P < 0.05 significant 527 
differences compared to controls. # P < 0.05 significant differences compared to isoproterenol 528 
group. @ P < 0.05 significant differences compared to isoproterenol-treated group with 529 
clopidogrel. 530 
Fig. 5. LC-HRESIMS analysis of DPP ethanolic extract. 531 
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Table 1  
Effect of DPP ethanolic extract on body weight, heart weight and heart weight/body weight ratio in isoproterenol induced myocardial infarction 
in rats. 
Parameters Control Isop Isop + Clop Isop + DPP 
Body weight (g) 176.66 ± 10.44 173.66 ± 13.41 174.5 ± 13.18 199.88 ± 3.06*#@ 
Heart weigt (g) 0.82 ± 0.16 1.14 ± 0.17* 0.92 ± 0.09# 1.02 ± 0.14*# 
Heart weight/body weight ratio 0.46 ± 0.08 0.65 ± 0.05* 0.54 ± 0.04# 0.51 ± 0.06# 
Values are given as mean ± SD for groups of six animals each. 
Statistically, values are presented as follows: * P < 0.05 significant differences compared to controls. # P < 0.05 significant differences compared 
to isoproterenol group @ P < 0.05 significant differences to rats treated with clopidogrel. 
 
Table 2 
 Effect of DPP ethanolic extract on plasma cardiac damage. 
 ALT (UI/L) LDH (UI/L) CPK  (UI/L) Troponin-T (ng/mL) 
Control 75.33 ± 5.82 588.5 ± 45.38 2811 ± 120.44 0.46 ± 0.1 
Isop 124 ± 31.08* 1591 ± 179.98* 4818.33 ± 401.07* 1.91 ± 0.23* 
Isop + Clop  73.83 ± 8.28*# 1057.16 ± 101.57*# 3518 ± 269.97*#  0.59 ± 0.04*# 
Isop + DPP 66.66 ± 1.63*#@ 807.33 ± 2.06*#@ 2974 ± 116.66*#@ 0.46 ± 0.25# 
Alanine aminotransferase (ALT), lactate dehydrogenase (LDH), creatine phosphokinase (CPK) and serum troponin-T level of control and 
experimental groups of rats. Values are given as mean ± SD for group of six rats.  
Values are statistically presented as follows: * P < 0.05 significant differences compared to controls. # P < 0.05 significant differences compared 
to isoproterenol group @ P < 0.05 significant differences to rats treated with clopidogrel. 
 
 
Table 3 
 Effect of DPP ethanolic extract on cholesterol and triglycerides levels. 
Parameters Control Isop Isop + Clop Isop + DPP 
Cholesterol (mmol/l) 1.57 ± 0.15 2.33 ± 0.22*  1.93 ± 0.16*# 1.85 ± 0.18*# 
Triglycerides (mmol/l) 0.70 ± 0.09 0.99 ± 0.25*  0.81 ± 0.11*# 0.65 ± 0.039*#@ 
Values are given as mean ± SD for groups of six animals each. 
Statistically, values are presented as follows: * P < 0.05 significant differences compared to controls. # P < 0.05 significant differences compared 
to isoproterenol group @ P < 0.05 significant differences to rats treated with clopidogrel. 
 
Table 4 
HRESIMS analysis of DPP ethanolic extract and literature review of their biological properties. 
HRESIMS 
a
 
Mol 
formula a 
Suggested compound b MS/MS 
fragments 
Biological properties Reference 
413.3775 C29H48O Stigmasterol 
(steroid) 
396.3751, 
353.3203, 
338.2968, 
257.2266 
stigmasterol, when fed, lowers plasma cholesterol levels, inhibits 
intestinal cholesterol and plant sterol absorption, and suppresses 
hepatic cholesterol and classic bile acid synthesis in Wistar as well as 
WKY rats. However, plasma and hepatic incorporation of stigmasterol 
is low. 
Stigmasterol inhibits excessive proliferation of vascular smooth 
muscle cells, a crucial event in the pathogenesis of several 
cardiovascular diseases, including atherosclerosis and restenosis. 
Batta et al., 2006 
 
 
 
Li et al., 2015 
415.3931 C29H50O β-Sitosterol 
(steroid) 
398.3907, 
355.3359, 
340.3125, 
257.2264  
β-sitosterol reduce plasma cholesterol by 18% and is poorly absorbed 
in the intestine. 
β -sitosterol possess cardioprotective role in isoproterenol -induced 
myocardial infarction in rats. 
Lei et al., 2015 
Ganapathy et al., 2014 
 
273.1844 C18H24O2 Estradiol 256.1822, Estrogen has been shown to increase expression of superoxide Lagranha et al., 2010 
(steroid) 239.1794 dismutase and inhibit NADPH oxidase activity, thereby reducing 
oxidative stress 
Estrogen acting via ERβ increases protein S-nitrosylation, a common 
post-translational protein modification, leading to cardioprotection 
17beta-estradiol downregulates tissue angiotensin-converting enzyme 
 
Lin et al., 2009 
 
Dean et al., 2005 
457.4045 C31H52O2 β-Sitosterol acetate 
(steroid) 
414.3856, 
398.3907 
Similar effects to β-Sitosterol Ganapathy et al., 2014 
Lei et al., 2015 
373.2327 C21H34O4 2β,3β,4β-
trihydroxypregn-16-
one  (steroid) 
356.2322, 
339.2295,  
322.2267 
No biological activity reported Tan et al., 2010 
324.9950 C14H6O8 Ellagic acid (Tannin) 307.9927, 
290.9905, 
273.9873, 
256.9845 
Oral pretreatment with ellagic acid was safe and effective in cardio 
protection against isoproterenol -induced arrhythmias, hypertrophy 
and myocardial necrosis. Anti-lipid peroxidation property and anti 
hyperlipidaemic activity through 3-hydroxy-3 methyl glutaryl CoA 
reductase inhibition by ellagic acid may be the reasons for the 
beneficial action of ellagic acid against experimentally induced 
myocardial infarction. 
Ellagic acid is a potent cardiac protective agent against doxorubicin- 
induced cardiac oxidative, inflammatory and apoptotic stress. 
ellagic acid showed some ACE inhibition at a concentration of 0.75 
mM, 
Kannan and Quine, 
2013 
 
 
 
 
Lin and Yin, 2013 
 
Al Shukor et al., 2013 
397.4049 C26H52O2 Cerotic Acid  
(fatty acid) 
380.4013 No biological activity reported.  
569.4355 C40H56O2 Lutein 
(carotenoid derivative) 
552.4321, 
535.4301 
Lutein may play a protective role in the prevention of early 
atherosclerosis 
Lutein supplementation significantly increased the serum 
concentrations of lutein with a decrease in carotid artery intima-media 
thickness being associated with lutein concentrations. 
Lutein supplementation reduces biomarkers of cardiovascular diseases 
risk via decreased lipid peroxidation and inflammatory response by 
Zou et al., 2011 
Zou et al., 2014 
 
 
Wang et al., 2013 
increasing plasma lutein concentrations and antioxidant capacity. 
397.3095 C27H46O2 δ-tocotrienol 
(carotenoid derivative) 
381.3152, 
365.3208 
δ-tocotrienol improved inflammation, heart structure and function as 
well as cardiovascular function in diet-induced obese rats. 
Diet supplementation with δ-tocotrienol, reduce cardiovascular risk 
factors in humans when used as nutritional supplements with, or 
without, other dietary changes. 
Wong et al., 2015 
 
Qureshi et al., 2012 
441.3209 C30H42O 8’-β-apocarotenol 
(carotenoid derivative) 
424.3107 No biological activity reported. 
Precursor to Vitamin A 
 
583.45288 C41H58O2 Taraxanthin 
(carotenoid derivative) 
566.4485 No biological activity reported.  
317.1708 C19H24O4 3, 5’-hydroxyprenyl-
5-prenyl-p-coumaric 
acid (coumarin) 
300.1720, 
272.1771, 
255.1743 
No biological activity reported.  
217.1181 C12H18O2 2,5-dimethoxy-p-
cymene (terpenoid) 
186.1015, 
155.0831 
No biological activity reported.  
261.1079 C13H18O4 Trans-isomyristicin 
(terpenoid) 
230.0917 No biological activity reported.  
413.1156 C20H22O8 5-hydroxy-
pentamethoxy-
flavanone (Flavonoid) 
396.1177, 
365.0990, 
334.0812, 
303.0628 
No biological activity reported.  
317.0658 C16H12O7 Isorhamnetin 
(Flavonoid) 
286.0472, 
269.0445 
Isorhamnetin produced endothelium-independent vasodilator effects in 
rat aorta, rat mesenteric arteries, rat portal vein and porcine coronary 
arteries. The arterial, venous and coronary vasodilator effects may 
contribute to the protective effects of flavonoids in ischaemic heart 
disease observed in epidemiological studies. 
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In 
Vivo and In Vitro 
Ibarra et al., 2002 
 
 
 
Sun et al., 2013 
291.0869 C15H14O6 Catechin 
(Flavonoid) 
274.0836, 
258.0887 
catechin is effective in reversing the impaired relaxation in restrictive 
cardiomyopathy myocardial cells and rescuing the restrictive 
Zhang et al., 2015 
 
cardiomyopathy mice with diastolic dysfunction. 
catechin treatment prevents diabetes mellitus-induced vascular 
endothelial dysfunction. It also prevents of diabetic vascular 
endothelial dysfunction through reduction in high glucose, vascular 
oxidative stress, and lipid peroxidation. 
Bhardwaj et al., 2014 
287.0553 C15H10O6 Luteolin 
(Flavonoid) 
270.0520, 
253.0495 
Luteolin yields cardioprotective effects 
Luteolin pretreatment conveys anti-apoptotic effects after myocardial 
ischemia/reperfusion injury. 
Luteolin indicated potent in vitro ACE inhibitory activity with IC50 
value of 23 µM. 
Nai et al., 2015 
Bian et al., 2015 
 
Guerrero et al., 2012 
301.1402 C18H20O4 5,7,4’-
trimethoxyflavane 
(Flavonoid) 
270.1250, 
239.1067, 
208.0883 
No biological activity reported.  
303.0499 C15H10O7 Quercitin 
(Flavonoid) 
286.0389 Quercitin provides cardiovascular protective effects  
Quercetin is a potent anti-atherosclerotic compound 
Quercitin indicated potent in vitro ACE inhibitory activity with IC50 
value of 43 µM. 
Malaguti et al., 2015 
Hung et al., 2015 
Guerrero et al., 2012 
271.0601 C15H10O5 Apigenin 
(Flavonoid) 
254.0574 Apigenin attenuates myocardial ischemia/reperfusion 
Apigenin ameliorates acute myocardial infarction of rats 
Apigenin indicated potent in vitro ACE inhibitory activity with IC50 
value of 196 µM. 
Yang et al., 2015 
Du et al., 2015 
Guerrero et al., 2012 
611.1608 C27H30O16 Rutin 
(Flavonoid glycoside) 
448.1009, 
302.0427, 
286.0472 
Rutin have a cardioprotective effects in ischaemia-reperfusion injury 
in both normal and diabetic rats, and that protection might be in part 
due to the attenuation of oxidative stress and moderate increment in 
antioxidant reserves. 
Rutin indicated potent in vitro ACE inhibitory activity with IC50 value 
of 64 µM. 
Annapurna et al., 2009 
 
 
Guerrero et al., 2012 
449.1075 C21H20O11 Quercitrin 
(Flavonoid glycoside) 
302.0421, 
286.0472 
Quercitrin have an inhibitory effect on the angiotensin-converting 
enzyme activity, similar to that of captopril. 
Hackl et al., 2002 
493.1345 C23H24O12 Morifonoside A 331.0815 No biological activity reported.  
(Flavonoid glycoside) 
449.1077 C21H20O11 Luteolin-7-O-
glucoside 
(Flavonoid glycoside) 
286.0472 Protection of Luteolin-7-O-Glucoside Against Doxorubicin-induced 
cardiotoxicity. 
Luteolin -7-O-glucoside have an inhibitory effect on the angiotensin-
converting enzyme 
Yao et al., 2015 
Simaratanamongkol et 
al., 2014 
153.0543 C8H8O3 Methyl-4-
hydroxybenzoate 
(Phenolic derivative) 
122.0362 safe food and cosmetic antibacterial and antifungal preservative. Soni et al., 2002 
179.0701 C10H10O3 Methyl-p-
hydroxycinnamate 
(Phenolic derivative) 
148.0522 p-coumaric acid protected the myocardial infarcted rat's heart against 
apoptosis by inhibiting oxidative stress. 
p-coumaric acid have Preventive effects of on myocardial infarct size 
in experimentally induced myocardial infarction. 
Stanley Mainzen Prince 
and Jyoti Roy., 2013 
Jyoti Roy and Stanley 
Mainzen Prince., 2013 
195.0654 C10H10O4 Ferulic Acid 
(Phenolic derivative) 
178.0626, 
147.0447 
Ferulic acid may contribute to prevention of chronic inflammatory 
diseases, a part of the pathophysiology of Cardiovascular Diseases 
Ferulic acid improved the structure and function of the heart and blood 
vessels in hypertensive rats. 
Ferulic acid indicated potent in vitro ACE inhibitory activity with IC50 
values of 10.898 +/- 0.430. 
Navarrete et al., 2015 
 
Alam et al., 2013 
 
Geng et al., 2010 
a High Resolution Electrospray Ionization Mass Spectrometry (HRESIMS) using Xcalibur 3.0 and allowing for M + H and M + Na adducts. 
b The suggested compound according to Dictionary of Natural Products (DNP 23.1, 2015 on DVD). 
 
 
